TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Sanjay Srivastava, PhD

Sanjay Srivastava

Sanjay Srivastava, PhD

  • Associate Academic Dean
  • Professor
Office Phone: 806-414-9211
Mail Address: 1406 S Coulter St
Amarillo TX 79106-1786


Dr. Sanjay K. Srivastava is a Professor of Biomedical Sciences specializing in Cancer Biology, Chemoprevention and Therapeutics. Prior to his arrival at TTUHSC, Dr. Srivastava served as an Assistant Professor in the Department of Pharmacology, University of Pittsburgh School of Medicine from 2000-2007 and was a full member of the University of Pittsburgh Cancer Institute. He did his post-doc from the University of Texas Medical Branch at Galveston, Texas from 1992-1995. Dr. Srivastava’s research is focused on melanoma, pancreatic, ovarian and breast cancer and is funded by grants from the National Cancer Institute, NIH. He has authored more than 100 research papers and is the Editor of three books. Dr. Srivastava is in the editorial board of several journals and is the member of societies including American Association for Cancer Research, Society of Toxicology and AAPS. He also serves in the grant review panels of National Institute of Health (NIH), Department of Defense and Susan G. Komen Breast Cancer Foundation. His research work has been featured by news agencies including BBC, MSNBC, CBS, ABC, Science News etc.

Research Interests

Cancer, chemoprevention, cell signaling, experimental therapeutics, metastasis, natural products, molecular pharmaology, redox signaling, carcinogenesis

Selected Publications:

  • Fofaria NM, Srivastava SK. Critical role of STAT3 in melanoma metastasis through anoikis resistance.. Oncotarget 2014;5(16):7051-64.
  • Gupta P, Wright S, Kim SH, Srivastava SK. Phenethyl isothiocyanate: A comprehensive review of anti-cancer mechanisms.. Biochimica et biophysica acta 2014;1846(2):405-424.
  • Gupta P, Kim B, Kim SH, Srivastava SK. Molecular targets of isothiocyanates in cancer: recent advances.. Molecular nutrition & food research 2014;58(8):1685-707.
  • Gupta P, Srivastava SK. HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer.. Molecular oncology 2014.
  • Wright S, Rewers-Felkins KA, Quinlin I, Chowdhury NI, Ahmed J, Eldridge PW, Srivastava SK, Pastan I. TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells.. Oncology letters 2014;7(6):2113-2117.